Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.57 |
| ▸ | MME | P08473 | 3/20 | 0.57 |
| ▸ | ANPEP | P15144 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 6/20 | 0.53 |
| ▸ | CTSC | P53634 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28064932 | 1.00 | LTA4H (0.57) | LTA4HMMEANPEPECE1ACE | |
| SCHEMBL8575450 | 0.93 | OPRD1 (0.59) | LTA4HMMEACE | |
| SCHEMBL8575457 | 0.93 | OPRD1 (0.59) | LTA4HMMEACE | |
| SCHEMBL29966332 | 0.91 | REN (0.57) | MMEACE | |
| SCHEMBL29350940 | 0.89 | OPRD1 (0.55) | MMEACE | |
| SCHEMBL31388294 | 0.89 | OPRD1 (0.57) | LTA4HMMEANPEPECE1 | |
| SCHEMBL29896984 | 0.87 | MME (0.52) | MMEACE | |
| SCHEMBL7318304 | 0.87 | CTSL (0.65) | LTA4HMMEANPEPECE1ACE | |
| SCHEMBL8068319 | 0.87 | MME (0.61) | MMEACECTSC | |
| SCHEMBL8068326 | 0.87 | MME (0.61) | MMEACECTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2631 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025042352-A2 | SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) MOUSE ANTIBODY SPECIFIC TO SAPOSIN-LIKE PROTEIN 2 OF THE LIVER FLUKE FASCIOLA GIGANTICA | BURAPHA UNIVERSITY (TH) | 2025-02-27 | — | — | WO | claimed |
| US-11801307-B2 | Antibody-polymer-drug conjugates | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2023-10-31 | — | — | US | claimed |
| EP-4045087-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2022-08-24 | — | — | EP | claimed |
| US-20220249682-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-08-11 | — | — | US | claimed |
| CN-114729002-B | Eluent collection during antibody chromatography | MORPHOSYS AG (DE) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-116194479-B | Anti-TAU antibodies | GT创新公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-106794263-B | Vaccine with antigen and interleukin-21 as adjuvant | 宾夕法尼亚大学理事会 | 2026-05-19 | — | — | CN | disclosed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260098097-A1 | IMMUNOTOXIN-BASED TARGETED THERAPY FOR CANCER | UNIV COLORADO REGENTS (US) | 2026-04-09 | — | — | US | disclosed |
| US-12521443-B2 | Conjugate production | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2026-01-13 | — | — | US | disclosed |
| US-12508303-B2 | Acetylation of Miro1 | UNIVERSITY OF SOUTH CAROLINA (US) | 2025-12-30 | — | — | US | disclosed |
| CN-113957087-A | Application of Sub gene in regulation and control of cold resistance of rice | 天津市农业科学院 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |
| CN-105646637-B | A kind of abiraterone derivative and preparation method thereof and medical usage | 四川海思科制药有限公司 | 2018-12-14 | — | — | CN | disclosed |
| CN-105646637-A | Abiraterone derivative, preparation method and medical applications thereof | 四川海思科制药有限公司 | 2016-06-08 | — | — | CN | disclosed |
| US-20110262962-A1 | METHOD FOR PRODUCING PEPTIDES | AJINOMOTO CO., INC. (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20070292916-A1 | MUTANT PROTEIN HAVING THE PEPTIDE-SYNTHESIZING ACTIVITY | AJINOMOTO CO., INC. (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1829968-A1 | MUTANT PROTEIN HAVING PEPTIDE-PRODUCTION ACTIVITY | Ajinomoto Co., Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070190602-A1 | Mutant protein having the peptide-synthesizing activity | AJINOMOTO CO., INC (JP) | 2007-08-16 | — | — | US | disclosed |